Observational studyBMC palliative care2018
Use of hospital palliative care according to the place of death and disease one year before death in 2013: a French national observational study.
Observational study in BMC palliative care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Computational definition of medical exclusion and feasibility of excluding people not eligible for French population-based colorectal cancer screening from the French medico-administrative database.BMC medical informatics and decision making · 2025Review
- Epidemiology, resource use, and treatment patterns of locally advanced or metastatic urothelial carcinoma in France.Future oncology (London, England) · 2025Article
- General practitioners and palliative care practices: a better knowledge of specific services is still needed.BMC health services research · 2024Article
- General practitioner residents and patients end-of life: involvement and consequences.BMC medical ethics · 2022Article
- Hospitalizations and emergency department visits trends among elderly individuals in proximity to death: a retrospective population-based study.Scientific reports · 2021Article
- Access to inpatient palliative care among cancer patients in France: an analysis based on the national cancer cohort.BMC health services research · 2020Article
- Cancer and end of life: the management provided during the year and the month preceding death in 2015 and causes of death in France.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020Article
- Management and intensity of medical end-of-life care in people with colorectal cancer during the year before their death in 2015: A French national observational study.Cancer medicine · 2019Observational
- Access to palliative care for cancer patients between diagnosis and death: a national cohort study.Clinical epidemiology · 2019Article
- Intensity of Care, Expenditure, and Place of Death in French Women in the Year Before Their Death From Breast Cancer: A Population-Based Study.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOnly limited data are available concerning the diseases managed before death and hospital palliative care (HPC) use according to place of death in France. We therefore conducted an observational study based on administrative health data in a large population to identify the diseases treated one year before death in 2013, the place of stay with or without hospital palliative care, and the place of death.
methodsFrench health insurance general scheme beneficiaries were identified in the National Health data Information System (Snds) with a selection of information. Diseases were identified by algorithms from reimbursement data recorded in the Snds database.
results347,253 people were included in this study (61% of all people who died in France). Place of death was short stay hospital for 51%, Rehab (7%), hospital at home (3%), skilled nursing home (13%) and other (26%). Chronic diseases managed in 2013 before death were cardiovascular/neurovascular diseases (56%), cancers (42%), and neurological and degenerative diseases (25%). During the year before death, 84% of people were hospitalized at least once, and 29% had received HPC. HPC was used by 52% of cancer patients (lung cancer: 62%; prostate cancer: 41%). In the absence of cancer, the use of HPC varied according to the disease: acute stroke: 24%, heart failure: 17%, dementia: 17%, multiple sclerosis: 23%.
conclusionsHealth administrative data can refine the knowledge of the care pathway prior to death and the HPC utilisation and can be useful to evaluate heath policies and improve monitoring and assessment of HPC use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.